Venture capitalists favor biotechnology over medical devices
by Amy Gillentine Published: February 3,2012
Tags: biotechnology, life sciences, medical devices, PriceWaterhouseCoopers, software, venture capital
Venture capital funding in the life sciences sector, which includes the biotechnology and medical device industries, increased 21 percent during 2011, according to a new PricewaterhouseCooper’s report, “Zigzagging Upward.” Venture capitalists invested a total of $7.5 billion in 785 life sciences deals during the year, topping 2010 performance despite a drop from the third to [...] [...]







